Psychopharmacology explores the use of medications to treat mental health disorders. From antidepressants to antipsychotics, understanding the mechanisms, efficacy, and side effects of these drugs is crucial. The Journal of Clinical Psychiatry offers in-depth insights into psychopharmacological treatments, their applications, and the latest research. Our expert editors curate content that is evidence-based and clinically relevant, ensuring psychiatrists are well-informed about the latest developments in medication-based treatments.
Psychopharmacology
Page 2
Recently published articles about Psychopharmacology
ASCP Corner
When Do Physical Symptoms After Antidepressant Cessation Reflect Pharmacodynamic versus Non-pharmacodynamic Clinical Phenomena?
August 6, 2026
Focuses on descriptive symptom phenomenology and strategies to minimize discomfort during antidepressant cessation, with possible explanations for unusual, delayed, or protracted symptoms in patients for whom non-pharmacodynamic features may...
Clinical and Practical Psychopharmacology
Gestational Exposure to Sterol Biosynthesis Disrupting Drugs and Risk of Autism Spectrum Disorder
June 15, 2026
Dr Andrade discusses a recent study of sterol biosynthesis disrupting drugs and argues that inadequate research methods disallow clinical application of the results.
Original Research
Innovation in Psychiatric Drug Development: A Quantitative Analysis of FDA-Approved Psychiatric Drugs, 2012–2024
January 12, 2026
Innovation in psychiatric drug development in the past 13 years was limited, with most new drugs representing incremental advances rather than groundbreaking innovations.
